In Vivo Function of the B7 Family of Costimulators
In Vivo Function of the B7 Family of Costimulators
批准号:
7846544
负责人:
Arlene H. Sharpe
金额:
$2.25万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-06-05 至 2010-09-30
关键词:
AddressAdoptive TransferAffectAttenuatedAutoimmune DiseasesAutoimmunityBehaviorCD4 Positive T LymphocytesCellsClinicalDataDefectDevelopmentDiseaseDoseEffector CellEmployee StrikesEncephalomyelitisEnvironmentEquilibriumExperimental Autoimmune EncephalomyelitisFamilyFamily memberGenerationsGoalsGrantHomingImmune responseIn VitroInterferon Type IIInterleukin-10Interleukin-12Interleukin-2LeadLigandsLymphoidMusNoseOptic NeuritisOralOrganPathogenicityPathway interactionsPeptidesPeripheralProductionRegulationRelative (related person)Research PersonnelResistanceRoleSecondary toSignal TransductionT-Cell ActivationT-LymphocyteTh1 CellsTissuesTransgenic MiceTransgenic OrganismsWild Type Mousecytokinefeedingin vivoinsightinterleukin-23migrationnoveloligodendrocyte-myelin glycoproteinprotective effectresearch studyresponsetool
中文摘要
本应用程序的总体目标是剖析最近发现的B7/CD28家族的功能角色
英文摘要
The overall goal of this application is to dissect the functional roles of the recently identified B7/CD28 family
members ICOS and PD-L1 in regulating mucosal tolerance. This focus is driven by our recent studies that
have identified essential, non-redundant roles for ICOS and PD-L1 in mucosal tolerance. We have found that
ICOS and PD-L1 have similar roles in controlling the ability of orally-induced regulatory T cells to exert their
protective effects. Each of these roles must be unique, since orally induced WT CD4+ Treg cannot function
following transfer into ICOS-/- or PD-L1-/- mice. In contrast, PD-L1, but not ICOS, is required for the
generation of functional orally induced CD4+ Treg. To investigate the relationships between ICOS and PD-
L1 in regulating mucosal tolerance, we will analyze the 1) role of ICOS in the generation and/or function of
pathogenic effector T cells (IL-12 driven IFN-g producing Th1 cells and IL-23 driven ThlL-17 cells), since the
impaired function of orally induced WT CD4+ T reg could be a primary defect or secondary to enhanced
pathogenicity of ICOS-/- effector cells 2) role of ICOS in controlling function of orally induced CD4+ Treg;
and 3) relationships between ICOS and PD-L1 in controlling functions of self reactive effector and orally
induced CD4+ T reg. These studies should reveal the relative roles of ICOS and PD-L1 in controlling the
balance between regulatory and encephalitogenic Th1 cells in vivo. We have assembled a number of novel
tools that will enable us to address these issues. To dissect the role of ICOS in mucosal tolerance, we have
developed ICOS-/- mice. Our PD-L1-/- mice will serve as a definitive tool to examine how PD-L1 regulates
the generation and function of orally-induced CD4+ Treg. We will use MOG35-55 specific TCR transgenic
mice to visualize the effects of ICOS and PD-L1 dysregulation on activation, migration and expansion of
naive and effector T cells in vivo, and development and behavior of orally induced Treg. These studies
should lead to insights into how ICOS and PD-L1 regulate the responses of self-reactive T cells.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Defining regulators of immunity to acute infection using CRISPR screens
-
批准号:10210502
-
项目类别:
-
资助金额:$10.99万
-
财政年份:2020
-
负责人:Arlene H. Sharpe
-
依托单位:
Abbreviated targeted therapy to improve anti-PD-1 inhibitor efficacy in melanoma
-
批准号:10153453
-
项目类别:
-
资助金额:$38.06万
-
财政年份:2018
-
负责人:Arlene H. Sharpe
-
依托单位:
Project 2: Measuring and modeling the tumor and immune microenvironment before and during therapy and at the time of drug resistance
-
批准号:10343840
-
项目类别:
-
资助金额:$30.14万
-
财政年份:2018
-
负责人:Arlene H. Sharpe
-
依托单位:
Abbreviated targeted therapy to improve anti-PD-1 inhibitor efficacy in melanoma
-
批准号:9906872
-
项目类别:
-
资助金额:$38.05万
-
财政年份:2018
-
负责人:Arlene H. Sharpe
-
依托单位:
Abbreviated targeted therapy to improve anti-PD-1 inhibitor efficacy in melanoma
-
批准号:9576657
-
项目类别:
-
资助金额:$39.83万
-
财政年份:2018
-
负责人:Arlene H. Sharpe
-
依托单位:
Defining regulators of immunity to acute infection using CRISPR screens
-
批准号:10207344
-
项目类别:
-
资助金额:$229.25万
-
财政年份:2017
-
负责人:Arlene H. Sharpe
-
依托单位:
Project 1: CRISPR screens to discover regulators of CD8 and CD4 cell fates and function
-
批准号:10207349
-
项目类别:
-
资助金额:$86.54万
-
财政年份:2017
-
负责人:Arlene H. Sharpe
-
依托单位:
Defining regulators of immunity to acute infection using CRISPR screens
-
批准号:9380804
-
项目类别:
-
资助金额:$246.29万
-
财政年份:2017
-
负责人:Arlene H. Sharpe
-
依托单位:
Core D: Mouse Perturbation Core
-
批准号:10207348
-
项目类别:
-
资助金额:$81.28万
-
财政年份:2017
-
负责人:Arlene H. Sharpe
-
依托单位:
Administrative Core
-
批准号:10207345
-
项目类别:
-
资助金额:$37.75万
-
财政年份:2017
-
负责人:Arlene H. Sharpe
-
依托单位:
Defining regulators of immunity to acute infection using CRISPR screens
-
批准号:10266219
-
项目类别:
-
资助金额:$10.99万
-
财政年份:2017
-
负责人:Arlene H. Sharpe
-
依托单位:
T Cell Costimulatory Pathways: Function and Interactions
-
批准号:9121451
-
项目类别:
-
资助金额:$3.96万
-
财政年份:2016
-
负责人:Arlene H. Sharpe
-
依托单位:
Project 1: Costimulation and Regulation of Anti-viral Immunity
-
批准号:9121455
-
项目类别:
-
资助金额:$53.35万
-
财政年份:2016
-
负责人:Arlene H. Sharpe
-
依托单位:
Project 1 - Modulation of Tolerance and Autoimmunity by Inhibitory Receptors
-
批准号:10023668
-
项目类别:
-
资助金额:$47.04万
-
财政年份:2015
-
负责人:Arlene H. Sharpe
-
依托单位:
Project 1 - Modulation of Tolerance and Autoimmunity by Inhibitory Receptors
-
批准号:10239110
-
项目类别:
-
资助金额:$45.63万
-
财政年份:2015
-
负责人:Arlene H. Sharpe
-
依托单位:
Modulation of Tolerance and Autoimmunity by Inhibitory Receptors
-
批准号:8854452
-
项目类别:
-
资助金额:$58.7万
-
财政年份:2015
-
负责人:Arlene H. Sharpe
-
依托单位:
Project 1 - Modulation of Tolerance and Autoimmunity by Inhibitory Receptors
-
批准号:10670295
-
项目类别:
-
资助金额:$45.63万
-
财政年份:2015
-
负责人:Arlene H. Sharpe
-
依托单位:
Project 1 - Modulation of Tolerance and Autoimmunity by Inhibitory Receptors
-
批准号:10663576
-
项目类别:
-
资助金额:$45.63万
-
财政年份:2015
-
负责人:Arlene H. Sharpe
-
依托单位:
Role of Costimulation in Control of the Effector and Regulatory T Cell Balance
-
批准号:8289441
-
项目类别:
-
资助金额:$62.9万
-
财政年份:2011
-
负责人:Arlene H. Sharpe
-
依托单位:
Role of Immune Regulatory Pathways in BRAF Targeted Therapy In Melanoma
-
批准号:8555326
-
项目类别:
-
资助金额:$24.84万
-
财政年份:2011
-
负责人:Arlene H. Sharpe
-
依托单位:
海外基金